Related Experiment Video
Updated: Dec 14, 2025

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
Published on: August 1, 2025
MicroRNAs in ascending thoracic aortic aneurysms
Areti Moushi1, Nir Pillar2, Anna Keravnou1,3
1Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Abstract:
Thoracic Aortic Aneurysm (TAA) is characterized by the dilation of the aorta and is fatal if not diagnosed and treated appropriately. The underlying genetic mechanisms have not been completely delineated, so better knowledge of the physiopathology of TAAs is needed to improve detection and therapy. MicroRNAs (miRNAs) regulate gene expression post-transcriptionally and are known to be involved in cardiovascular diseases (CVDs). The current study aimed to identify miRNAs that can be used as possible biomarkers for the early diagnosis of patients with ascending TAAs (ATAAs). MiRNA expression was profiled by NanoString nCounter technology using 12 samples including tissue and pre- and post-surgical plasma from ATAA patients. Four miRNAs were selected and further validated by real time polymerase chain reaction (RT-PCR) in 22 plasma samples from which three miRNAs (hsa-miR140-5p, hsa-miR-191-5p and hsa-miR-214-3p) showed significant expression level differences between the two types of plasma samples. Further analyses of the corresponding predicted target genes by these miRNAs, revealed two genes (Myotubularin-related protein 4 (MTMR4) and Phosphatase 1 catalytic subunit β (PPP1CB)) whose expression was inversely correlated with the expression of their respective miRNAs. Overall, in this pilot study, we identified three miRNAs that might serve as potential biomarkers and therapeutic targets in ATAA.
Insights
Researchers identified three microRNAs (miRNAs) as potential early diagnostic biomarkers for ascending thoracic aortic aneurysm (aTAA). These findings may also lead to new therapeutic targets for this fatal cardiovascular disease.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Biomarker Discovery
Background:
- Thoracic Aortic Aneurysm (TAA) involves aortic dilation and is often fatal if untreated.
- The genetic underpinnings of TAA remain incompletely understood, necessitating research into its pathophysiology.
- MicroRNAs (miRNAs) are key post-transcriptional regulators implicated in cardiovascular diseases (CVDs).
Purpose of the Study:
- To identify potential microRNA (miRNA) biomarkers for the early diagnosis of ascending thoracic aortic aneurysms (ATAAs).
- To explore novel therapeutic targets for ATAA based on miRNA expression profiles.
Main Methods:
- MiRNA expression profiling was performed using NanoString nCounter technology on tissue and plasma samples from ATAA patients.
- Quantitative validation of selected miRNAs was conducted using real-time polymerase chain reaction (RT-PCR).
- Bioinformatic analysis identified predicted target genes and their correlation with miRNA expression.
Main Results:
- Three specific miRNAs (hsa-miR140-5p, hsa-miR-191-5p, and hsa-miR-214-3p) exhibited significant expression differences in plasma samples.
- Expression levels of two target genes, MTMR4 and PPP1CB, were inversely correlated with their corresponding miRNAs.
- This pilot study highlights potential diagnostic and therapeutic avenues for ATAA.
Conclusions:
- Identified three miRNAs as potential non-invasive biomarkers for early ATAA detection.
- These miRNAs and their target genes represent potential targets for future ATAA therapies.
- Further research is warranted to validate these findings and explore therapeutic applications.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care
Aneurysm I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Thoracic Aorta

